Azamian Bobak's most recent trade in Tarsus Pharmaceuticals Inc was a trade of 6,000 Common Stock done at an average price of $50 . Disclosure was reported to the exchange on Aug. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 11 Aug 2025 | 6,000 | 818,106 | - | 50 | 300,000 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 24 Mar 2025 | 6,000 | 824,106 | - | 50 | 300,000 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 47.40 per share. | 18 Mar 2025 | 8,551 | 62,169 | - | 47.4 | 405,317 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 50.11 per share. | 18 Mar 2025 | 8,534 | 53,635 | - | 50.1 | 427,639 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 46.29 per share. | 18 Mar 2025 | 7,131 | 70,720 | - | 46.3 | 330,094 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 51,395 | 77,851 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 23,121 | 69,364 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 16,975 | 33,950 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 11,299 | 11,300 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 90,736 | 90,736 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 59,512 | 59,512 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 28,274 | 36,871 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 16,975 | 50,925 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 11,299 | 22,599 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 30.60 per share. | 15 Mar 2024 | 10,415 | 26,456 | - | 30.6 | 318,699 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 136,947 | 136,947 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 92,485 | 92,485 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Azamian Bobak | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 20.22 per share. | 27 Dec 2023 | 8,000 | 830,106 | - | 20.2 | 161,760 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 20.36 per share. | 20 Dec 2023 | 30,557 | 838,106 | - | 20.4 | 622,141 | Common Stock |
| Tarsus Pharmaceuticals Inc | Azamian Bobak | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 19.96 per share. | 20 Dec 2023 | 9,443 | 868,663 | - | 20.0 | 188,482 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 17.23 per share. | 23 Aug 2023 | 8,000 | 902,106 | - | 17.2 | 137,840 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 20.04 per share. | 19 Jul 2023 | 99,726 | 910,106 | - | 20.0 | 1,998,509 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 19.28 per share. | 19 Jul 2023 | 4,174 | 1,009,832 | - | 19.3 | 80,475 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 17.35 per share. | 12 Jul 2023 | 9,000 | 1,014,006 | - | 17.4 | 156,150 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 18.63 per share. | 21 Jun 2023 | 8,000 | 1,023,006 | - | 18.6 | 149,040 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 18.58 per share. | 14 Jun 2023 | 9,000 | 1,031,006 | - | 18.6 | 167,220 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 08 Jun 2023 | 3,100 | 1,040,006 | - | 20.0 | 62,031 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.90 per share. | 17 May 2023 | 8,000 | 1,043,106 | - | 15.9 | 127,200 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 16.80 per share. | 10 May 2023 | 9,000 | 1,051,106 | - | 16.8 | 151,200 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.10 per share. | 28 Apr 2023 | 5,841 | 1,060,106 | - | 15.1 | 88,199 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.13 per share. | 28 Apr 2023 | 4,278 | 1,065,947 | - | 15.1 | 64,726 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.03 per share. | 21 Apr 2023 | 2,311 | 1,070,225 | - | 15.0 | 34,734 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 13.60 per share. | 19 Apr 2023 | 8,000 | 1,072,536 | - | 13.6 | 108,800 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 12.15 per share. | 21 Mar 2023 | 737 | 8,597 | - | 12.2 | 8,955 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 12.64 per share. | 21 Mar 2023 | 709 | 9,334 | - | 12.6 | 8,962 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 12.89 per share. | 21 Mar 2023 | 679 | 10,043 | - | 12.9 | 8,752 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 17 Mar 2023 | 795 | 11,463 | - | 13.3 | 10,558 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 17 Mar 2023 | 741 | 10,722 | - | 12.6 | 9,344 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 11,299 | 13,049 | - | - | Common Stock | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 11,299 | 33,898 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 13.79 per share. | 15 Mar 2023 | 8,000 | 1,080,536 | - | 13.8 | 110,320 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 13.43 per share. | 15 Mar 2023 | 791 | 12,258 | - | 13.4 | 10,623 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 100,242 | 100,242 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 67,900 | 67,900 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.02 per share. | 08 Mar 2023 | 4,853 | 1,089,253 | - | 15.0 | 72,892 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 08 Mar 2023 | 717 | 1,088,536 | - | 15.0 | 10,762 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.28 per share. | 15 Feb 2023 | 8,000 | 1,094,106 | - | 15.3 | 122,240 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.14 per share. | 08 Feb 2023 | 9,000 | 1,102,106 | - | 15.1 | 136,260 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.45 per share. | 23 Jan 2023 | 4,856 | 1,111,106 | - | 15.4 | 75,025 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 18 Jan 2023 | 8,000 | 1,116,613 | - | 14.6 | 116,480 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 18 Jan 2023 | 240 | 1,116,373 | - | 15 | 3,600 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.11 per share. | 11 Jan 2023 | 3,904 | 1,124,613 | - | 15.1 | 58,989 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.17 per share. | 09 Jan 2023 | 905 | 1,128,517 | - | 15.2 | 13,729 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.15 per share. | 09 Jan 2023 | 729 | 1,129,422 | - | 15.1 | 11,044 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 06 Jan 2023 | 411 | 1,129,740 | - | 15 | 6,165 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 14.57 per share. | 21 Dec 2022 | 8,000 | 1,130,151 | - | 14.6 | 116,560 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.01 per share. | 16 Dec 2022 | 535 | 1,138,151 | - | 15.0 | 8,030 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President/CEO and Board Chair | Sale of securities on an exchange or to another person at price $ 15.08 per share. | 14 Dec 2022 | 6,420 | 1,138,686 | - | 15.1 | 96,814 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.81 per share. | 16 Nov 2022 | 7,255 | 1,145,851 | - | 16.8 | 121,957 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.31 per share. | 16 Nov 2022 | 745 | 1,145,106 | - | 17.3 | 12,896 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.87 per share. | 09 Nov 2022 | 9,000 | 1,153,106 | - | 17.9 | 160,830 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.91 per share. | 19 Oct 2022 | 7,900 | 1,162,206 | - | 16.9 | 133,589 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.60 per share. | 19 Oct 2022 | 100 | 1,162,106 | - | 17.6 | 1,760 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.76 per share. | 12 Oct 2022 | 6,179 | 1,172,927 | - | 15.8 | 97,381 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.24 per share. | 12 Oct 2022 | 2,821 | 1,170,106 | - | 16.2 | 45,813 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.30 per share. | 21 Sep 2022 | 7,900 | 1,179,206 | - | 16.3 | 128,770 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.05 per share. | 21 Sep 2022 | 100 | 1,179,106 | - | 17.1 | 1,705 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.01 per share. | 14 Sep 2022 | 9,000 | 1,187,106 | - | 16.0 | 144,090 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.50 per share. | 17 Aug 2022 | 7,264 | 1,196,842 | - | 16.5 | 119,856 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.44 per share. | 17 Aug 2022 | 736 | 1,196,106 | - | 17.4 | 12,836 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 154,067 | 154,067 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 45,197 | 45,197 | - | - | Restricted Stock Units | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 27.76 per share. | 01 Nov 2021 | 5,033 | 1,210,739 | - | 27.8 | 139,716 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 28.21 per share. | 01 Nov 2021 | 800 | 1,209,939 | - | 28.2 | 22,568 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.44 per share. | 12 Oct 2021 | 4,698 | 1,215,772 | - | 26.4 | 124,215 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.49 per share. | 12 Oct 2021 | 833 | 1,220,470 | - | 25.5 | 21,233 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 08 Oct 2021 | 302 | 1,221,303 | - | 25.0 | 7,555 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.23 per share. | 01 Sep 2021 | 5,733 | 1,221,705 | - | 25.2 | 144,661 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 26.40 per share. | 01 Sep 2021 | 100 | 1,221,605 | - | 26.4 | 2,640 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.07 per share. | 10 Aug 2021 | 1,917 | 1,227,438 | - | 25.1 | 48,061 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 10 Aug 2021 | 103 | 1,229,355 | - | 25 | 2,575 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 06 Aug 2021 | 1,616 | 1,230,285 | - | 25 | 40,400 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 06 Aug 2021 | 727 | 1,229,558 | - | 25 | 18,175 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.13 per share. | 06 Aug 2021 | 100 | 1,229,458 | - | 25.1 | 2,513 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 05 Aug 2021 | 1,370 | 1,231,901 | - | 25 | 34,250 | Common Stock |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 204,998 | 204,998 | - | - | Stock Option (right to buy) | |
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO, Ten Percent Owner | 20 Oct 2020 | 21,575 | 1,233,271 | - | - | Common Stock | ||
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO, Ten Percent Owner | 20 Oct 2020 | 21,575 | 0 | - | - | Series A Preferred Stock | ||
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO, Ten Percent Owner | 20 Oct 2020 | 1,750 | 1,750 | - | - | Common Stock | ||
| Tarsus Pharmaceuticals Inc | Bobak Azamian | Director, President and CEO, Ten Percent Owner | 20 Oct 2020 | 1,750 | 0 | - | - | Series B Preferred Stock |